AIDS Healthcare Foundation (AHF) reported on Wednesday that the US will have 3m vaccine doses per day available by April in the fight against the COVID-19 variants.
In conjunction, the company's Ryan White HIV Clinics will offer its sites to administer the COVID-19 vaccines.
On Tuesday, AstraZeneca, Johnson & Johnson, Moderna, Novavax and Pfizer have reportedly testified at the US House of Representatives Energy and Commerce Subcommittee on Oversight and Investigations. Each company presented the scaled-up production numbers for the vaccines that have been approved by the US Food and Drug Administration (FDA).
AHF is the largest global AIDS organization and currently provides medical care and/or services to over 1.5m people in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region as well as Eastern Europe.
Galera Therapeutics sells dismutase mimetics portfolio to Biossil in USD108.5m agreement
Arcturus reports interim Phase 2 data for ARCT-032 in cystic fibrosis
Sanofi's efdoralprin alfa shows superior results in phase 2 study for AATD
FDA accepts Xspray Pharma's NDA for XS003 with PDUFA date set for June 2026
Citius Oncology and McKesson sign US distribution agreement for LYMPHIR
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
Genentech's Gazyva (obinutuzumab) receives US FDA approval to treat adults with lupus nephritis
AstraZeneca wins US FDA approval for Tezspire in chronic rhinosinusitis with nasal polyps
Antengene reveals ATG-022 clinical data at ESMO 2025
WeightWatchers launches RxFlexFund to expand affordable GLP-1 access for employers and employees
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Merck reports positive Phase 3 data for investigational two-drug HIV regimen doravirine/islatravir
60 Degrees reports first patient has tested negative for babesiosis in tafenoquine study